a month ago
AUTL
AnalystsGil BlumGil Blum's Stock Forecasts
AnalystsGil Blum
Sectors:
Industries:
Analyst Ranking
Top 1%
#16 out of 4586 analysts
Average Return
+23.32%
Win Rate
58%147 out of 252
Risk vs Reward
Poor
Good
Gil Blum's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | +367.67% | $0.67 | $3.11 | 2023-06-28 - 2024-05-15 | Buy |
Mereo Biopharma Group PLCMREO | +364.14% | $0.71 | $3.30 | 2023-03-29 - 2024-03-28 | Buy |
Taysha Gene Therapies IncTSHA | +341.54% | $0.65 | $2.87 | 2023-03-28 - 2024-03-28 | Buy |
Shattuck Labs IncSTTK | +276.04% | $2.17 | $8.16 | 2023-08-10 - 2024-05-15 | Buy |
Cti Biopharma CorpCTIC | +267.07% | $1.64 | $6.02 | 2021-11-30 - 2022-11-30 | Buy |
Gil Blum Analyst Color
Get additional color on Gil Blum's coverage of popular stocks
2 months ago
AUTL
Gil Blum's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | 16 | Buy | $7.00 | +125.08% | Reiterates | 2 days ago |
Generation Bio CoGBIO | 11 | Buy | $10.00 | +163.85% | Reiterates | 2 days ago |
Nurix Therapeutics IncNRIX | 15 | Buy | $31.00 | +94.97% | Reiterates | 2 days ago |
Nkarta IncNKTX | 11 | Buy | $13.00 | +88.95% | Maintains | 3 days ago |
Tscan Therapeutics IncTCRX | 1 | Buy | $11.00 | +23.18% | Reiterates | 4 days ago |
Arcellx IncACLX | 15 | Buy | $81.00 | +56.61% | Reiterates | 6 days ago |
Recursion Pharmaceuticals IncRXRX | 14 | Buy | $17.00 | +69.83% | Reiterates | 7 days ago |
Crispr Therapeutics AgCRSP | 13 | Buy | $88.00 | +54.49% | Maintains | 8 days ago |
Immunocore Holdings PLCIMCR | 4 | Buy | $81.00 | +44.62% | Reiterates | 8 days ago |
Cartesian Therapeutics IncRNAC | 11 | Buy | $42.00 | +57.60% | Reiterates | 8 days ago |
Rocket Pharmaceuticals IncRCKT | 13 | Buy | $53.00 | +124.01% | Reiterates | 10 days ago |
Nextcure IncNXTC | 8 | Buy | $4.00 | +140.96% | Reiterates | 13 days ago |
Shattuck Labs IncSTTK | 10 | Buy | $12.00 | +47.06% | Reiterates | 14 days ago |
Geron CorpGERN | 15 | Buy | $5.00 | +28.21% | Reiterates | 14 days ago |
Sarepta Therapeutics IncSRPT | 19 | Buy | $166.00 | +25.28% | Reiterates | 15 days ago |
G1 Therapeutics IncGTHX | 13 | Buy | $12.00 | +155.86% | Reiterates | 15 days ago |
Celcuity IncCELC | 8 | Buy | $24.00 | +39.29% | Reiterates | a month ago |
I MabIMAB | 12 | Buy | $6.00 | +229.67% | Reiterates | a month ago |
Autolus Therapeutics PLCAUTL | 17 | Buy | $9.00 | +129.01% | Reiterates | a month ago |
Mereo Biopharma Group PLCMREO | 9 | Buy | $6.00 | +89.27% | Reiterates | a month ago |
Gamida Cell LtdGMDAQ | 8 | Buy | $6.00 | +18,081.82% | Reiterates | 5 months ago |
Cti Biopharma CorpCTIC | 5 | Buy | $9.00 | N/A | Reiterates | a year ago |
Avrobio IncAVRO | 4 | Buy | $6.00 | N/A | Reiterates | a year ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Amicus Therapeutics IncFOLD | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.